Skip to main content
. 2019 Mar 17;2019:9394615. doi: 10.1155/2019/9394615

Figure 6.

Figure 6

The shROR1 CSC vaccination decreased the antitumor ability. (a) Tumor size images on day 48 from the HO8910 tumor-bearing nude mice immunized initially with the 2 × 105 shROR1 HO8910 CSC and other control vaccines. (b) Tumor size images on day 80 from the ID8 tumor-bearing mice immunized with the 2 × 105 shROR1 ID8 cancer stem-like cell and other control vaccines. A total of three times, with an interval of 10 days between the immunizations, followed by a challenge with 1 × 106 HO8910 cells (a) or 2 × 106 ID8 cells (b) at one week after final vaccination. (c, d) Kinetic quantification of tumor sizes. (e, f) Tumor-free mice. All the data represent the mean ± SD (n = 6 per group; representative images). Statistically significant differences between the different groups were indicated.